| __timestamp | Catalyst Pharmaceuticals, Inc. | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 10117774 | 85181000 |
| Thursday, January 1, 2015 | 11801342 | 135253000 |
| Friday, January 1, 2016 | 11369941 | 162297000 |
| Sunday, January 1, 2017 | 11375237 | 198442000 |
| Monday, January 1, 2018 | 19919204 | 226616000 |
| Tuesday, January 1, 2019 | 18842752 | 299726000 |
| Wednesday, January 1, 2020 | 16496715 | 335375000 |
| Friday, January 1, 2021 | 16936000 | 505748000 |
| Saturday, January 1, 2022 | 19789000 | 590453000 |
| Sunday, January 1, 2023 | 93150000 | 849658000 |
Infusing magic into the data realm
In the competitive world of pharmaceuticals, research and development (R&D) spending is a critical indicator of innovation and future growth. Over the past decade, Jazz Pharmaceuticals plc and Catalyst Pharmaceuticals, Inc. have demonstrated contrasting trajectories in their R&D investments.
From 2014 to 2023, Jazz Pharmaceuticals consistently outpaced Catalyst Pharmaceuticals, with R&D expenses growing by nearly 900% compared to Catalyst's 800% increase. Jazz's commitment to innovation is evident, with its R&D spending peaking at approximately $850 million in 2023, a significant leap from $85 million in 2014. Meanwhile, Catalyst's R&D expenses, though more modest, surged to around $93 million in 2023 from $10 million in 2014.
This data underscores the strategic priorities of these companies, with Jazz Pharmaceuticals investing heavily in its future pipeline, while Catalyst Pharmaceuticals maintains a more conservative approach.
Research and Development Investment: Johnson & Johnson vs Catalyst Pharmaceuticals, Inc.
Comparing Innovation Spending: Gilead Sciences, Inc. and Catalyst Pharmaceuticals, Inc.
R&D Insights: How Bio-Techne Corporation and Catalyst Pharmaceuticals, Inc. Allocate Funds
Research and Development Investment: BioMarin Pharmaceutical Inc. vs Jazz Pharmaceuticals plc
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Alpine Immune Sciences, Inc.
R&D Insights: How Jazz Pharmaceuticals plc and Ultragenyx Pharmaceutical Inc. Allocate Funds
Comparing Innovation Spending: Jazz Pharmaceuticals plc and MorphoSys AG
Research and Development Investment: Pharming Group N.V. vs Catalyst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Grifols, S.A. vs Catalyst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Corcept Therapeutics Incorporated and Catalyst Pharmaceuticals, Inc.
Comparing Innovation Spending: CymaBay Therapeutics, Inc. and Catalyst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Catalyst Pharmaceuticals, Inc. and Evotec SE